Researchers show potential benefits of delaying second mRNA COVID-19 vaccine dose
The currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the severe acute respiratory syndrome (SARS-CoV-2)
Read more